(Q38049367)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23036075%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23036075%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

9 March 2020

main subject

0 references

author

Bo Xiao

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23036075%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Didier Merlin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23036075%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

5 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23036075%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Delivery

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23036075%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23036075%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23036075%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

1393-1407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23036075%20AND%20SRC:MED&resulttype=core&format=json

CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Treatment of inflammatory bowel disease (IBD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Alternative drug delivery approaches for the therapy of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

MMPs in the gut: inflammation hits the matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Role of cytokines in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Inflammatory bowel disease—from mechanisms to treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Crohn's targeted therapy: myth or real goal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Clinical implications of mucosal healing for the management of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Mesalazine in inflammatory bowel disease: a trendy topic once again?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Polymeric nanoparticles for the selective therapy of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Novel drug delivery strategies for the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Future therapeutic approaches for inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Oral drug delivery research in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Upper gastrointestinal (GI) pH in young, healthy men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Oral colon delivery of insulin with the aid of functional adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Microencapsulation of probiotics for gastrointestinal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Mucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Mucins in the gastrointestinal tract in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Polymeric micelles for oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Immune dysfunction in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Emerging immunological targets in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

On the cellular processing of non-viral nanomedicines for nucleic acid delivery: mechanisms and methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

A review of stimuli-responsive nanocarriers for drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Endosomal escape pathways for delivery of biologicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Administration, distribution, metabolism and elimination of polymer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Nuclear drug delivery for cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Nuclear drug delivery to target tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Construction of cell penetrating peptide vectors with N-terminal stearylated nuclear localization signal for targeted delivery of DNA into the cell nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Synthetic DNA delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

New oral delivery systems for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Time-controlled oral delivery systems for colon targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Modified-release solid formulations for colonic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Development and in-vitro evaluation of a colon-specific controlled release drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

A potential approach for decreasing the burst effect of protein from PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Chitosan microparticles containing plasmid DNA as potential oral gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Colonic delivery of carboxyfluorescein by pH-sensitive microspheres in experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Design of pH-sensitive microspheres for the colonic delivery of the immunosuppressive drug tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Biodegradable microparticles as a two-drug controlled release formulation: a potential treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Protein-based nanocarriers as promising drug and gene delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Synthesis and characterization of N-(2-hydroxy)propyl-3-trimethyl ammonium chitosan chloride for potential application in gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Development of polycaprolactone/chitosan blend porous scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Prohibitin protects against oxidative stress in intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Oral somatic transgene vaccination using attenuated S. typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Engineered E. coli delivers therapeutic genes to the colonic mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Physiology and genetics of xylan degradation by gastrointestinal tract bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Peroral gene therapy of lactose intolerance using an adeno-associated virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Enhanced transduction of colonic cell lines in vitro and the inflamed colon in mice by viral vectors, derived from adeno-associated virus serotype 2, using virus-microbead conjugates bearing lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Mucoadhesive polymeric platforms for controlled drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

New glycoprotein-associated amino acid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

Oral gene delivery: Strategies to improve stability of pDNA towards intestinal digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

HIV-1 Trafficking to the Dendritic Cell-T-Cell Infectious Synapse Uses a Pathway of Tetraspanin Sorting to the Immunological Synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.730517

10.1517/17425247.2012.730517

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23036075%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference